-
Oppenheimer Reiterates Outperform on Sequenom
Tuesday, July 12, 2011 - 8:19am | 121Oppenheimer is out with its report today on Sequenom (NASDAQ: SQNM), reiterating Outperform. In a note to clients, Oppenheimer writes, "Today SQNM announced a three-year supply agreement with ILMN (NASDAQ: ILMN). Under the terms of the arrangement, SQNM will purchase ILMN sequencing technologies (...
-
Stocks to Watch for Tuesday 07/12/11: Fresh 52 Week Highs and Lows
Monday, July 11, 2011 - 5:09pm | 1546Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels. The following stocks hit new 52-week highs in Monday's trading session (listed from highest total volume to lowest): 1) BioSante Pharmaceuticals (NASDAQ: BPAX...
-
Ladenburg Thalmann Comments On Seracare Life Sciences Bid
Monday, July 11, 2011 - 9:06am | 76According to Ladenburg Thalmann, Seracare Life Sciences (NASDAQ: SRLS) and been the subject of an unsolicited $4.25 offer. Ladenburg Thalmann said that on 6/23/11, an investor group disclosed an unsolicited bid to acquire SRLS for $4.25 per share in cash with a deadline of 5:00 PM EST 7/11/11 for...
-
Deutsche Bank Updates 7/11/11
Monday, July 11, 2011 - 7:49am | 998Deutsche Bank made a number of updates in a research report published today. Affymetrix (NASDAQ: AFFX) had its rating maintained at Hold. At the same time, its price target has been raised from $6 to $7. On Friday, AFFX added 3.03% to its value to end the week at $6.79....
-
Deutsche Bank Has Buy On Thermo Fisher Scientific
Monday, July 11, 2011 - 7:41am | 98Deutsche Bank has a Buy rating and a $78 price target on shares of Thermo Fisher Scientific Inc. (NYSE: TMO). In a note to clients, Deutsche Bank writes, "We estimate TMO should trade at 17.5-19.5x our $4.20 FY11 EPS estimate and 14-16x our $5.25 FY12 EPS estimate (including FAS-123 expenses)....
-
Sequenom Announces Multi-Year Supply Agreement With Illumina
Monday, July 11, 2011 - 7:01am | 176Sequenom, Inc. (NASDAQ: SQNM) today announced it has signed a three-year supply agreement with Illumina (NASDAQ: ILMN). Under the terms of the agreement, Sequenom and its subsidiaries will purchase Illumina's sequencing equipment and consumables for use in the development of a noninvasive test...
-
Deutsche Bank Healthcare Services PT Changes 7/11
Monday, July 11, 2011 - 6:06am | 135Deutsche Bank has changed price targets on the following companies: Affymetrix (NASDAQ: AFFX) - Hold, tgt $6 to $7, Agilent Technologies (NYSE: A) - Buy, tgt $64 to $61, Bruker Corp. (NASDAQ: BRKR)- Hold, tgt $22.5 to $22, Illumina (NASDAQ: ILMN) - Buy, tgt $84 to $82.5, Life Technologies...
-
Stocks to Watch for Monday 07/11/11: Fresh 52 Week Highs and Lows
Sunday, July 10, 2011 - 6:15pm | 2231Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels. The following stocks hit new 52-week highs in Friday's trading session (listed from highest total volume to lowest): 1) Melco Crown Entertainment (NASDAQ:...
-
Oppenheimer Reiterates Outperform and PT of $9 on Sequenom
Friday, July 8, 2011 - 8:59am | 41Oppenheimer reiterated its Outperform rating on Sequenom (NASDAQ: SQNM). At the same time, the rating agency left its price target on the company's stock unchanged at $9. On Thursday, Sequenom closed the day at $7.90.
-
Morning Market Losers
Thursday, July 7, 2011 - 10:02am | 105Lumber Liquidators Holdings Inc (NYSE: LL) dipped 20.79% to $20.31 at 9:55 am. LL lowered its full-year forecast and projected weaker-than-expected results for the second quarter. Affymetrix Inc (NASDAQ: AFFX) fell 18.63% to $6.51. AFFX issued downbeat Q2 revenue projections. Magyar Bancorp Inc (...
-
Biggest Pre-Market Winners and Losers
Thursday, July 7, 2011 - 9:24am | 219Winners: Target (NYSE: TGT) is up over 6.50%, trading near $51.60 after reporting positive June sales results. Amphenol (NYSE: APH) is up over 5.50%, trading near $57.40. Kohl's (NYSE: KSS) is up over 5%, trading near $54.80 after reporting positive June sales results. Apollo Group (NASDAQ:...
-
Benzinga's Top Pre-Market NASDAQ Losers
Thursday, July 7, 2011 - 8:30am | 113Affymetrix Inc (NASDAQ: AFFX) dipped 17.63% to $6.59 in the pre-market session. AFFX issued downbeat Q2 revenue projections. Quantum Fuel Systems Technologies Worldwide Inc (NASDAQ: QTWW) dropped 6.76% to $4 in the pre-market trading. QTWW's trailing-twelve-month operating margin is -82.93%....
-
Piper Jaffray Overweight On Exelixis
Thursday, July 7, 2011 - 7:51am | 132Piper Jaffray has an Overweight rating and a $13 price target on shares of Exelixis, Inc. (NASDAQ: EXEL). In a note to clients, Piper Jaffray writes, "Exelixis has extended the timeline to report pivotal Phase III data for Cabozantinib in metastatic thyroid cancer (MTC) until later this quarter....
-
Morgan Stanley Discontinuations 7/6 Continued
Thursday, July 7, 2011 - 7:19am | 103Morgan Stanley has discontinued coverage on the following companies: Affymetrix (NASDAQ: AFFY) Pacific Biosciences (NASDAQ: PACB) Gen-Probe (NASDAQ: GPRO) Thermo Fisher Scientific (NYSE: TMO) Myriad Genetics (NASDAQ: MYGN) Waters Corporation (NYSE: WAT) Ilumina (NASDAQ: ILMN) Life Technology (...
-
Piper Jaffray Maintains Neutral on Affymetrix
Thursday, July 7, 2011 - 7:19am | 110Piper Jaffray is out with its report today on Affymetrix (NASDAQ: AFFX), maintaining Neutral. In a note to clients, Piper Jaffray writes, "Affymetrix announced preliminary 2Q11 top-line results, with total revenue anticipated to be in the $64M-$65M range, below our previous $75.3M and Street...